Literature DB >> 16451411

Alert surveillance of intensive care unit-acquired Acinetobacter infections in a Sicilian hospital.

A Agodi1, R Zarrilli, M Barchitta, A Anzaldi, A Di Popolo, A Mattaliano, E Ghiraldi, S Travali.   

Abstract

The epidemiological impact of Acinetobacter baumannii nosocomial infections in a Sicilian intensive care unit (ICU) was investigated to determine the Acinetobacter-specific infection rates, to estimate the preventable proportion of Acinetobacter infections, i.e., those resulting from cross-transmission, and to investigate the molecular epidemiology of antimicrobial resistance in Acinetobacter. The impact of Acinetobacter nosocomial infection in the ICU was determined to be 3.0 new cases per 100 admissions. Site-specific rates confirmed that ICU-acquired pneumonia was the most important infection type. The incidence rate, adjusted by the number of patient-days, was 3.3 infections/1000 patient-days. The estimated preventable proportion of A. baumannii nosocomial infections in the ICU was 66.7%. A class 1 integron, characterised by its gene cassette content, was present in all A. baumannii isolates of four different pulsed-field gel electrophoresis types, and was associated significantly with clones implicated in cross-transmission episodes. Furthermore, the same integron was detected in two genetically distinct isolates responsible for recurrent infection in the same patient, suggesting the occurrence of horizontal gene transfer in vivo. Even in an endemic setting with low infection rates, spread of A. baumannii was caused mainly by infection control shortcomings that require appropriate surveillance and control policies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16451411     DOI: 10.1111/j.1469-0691.2005.01339.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  9 in total

1.  Four Year Trend of Carbapenem-Resistance in Newly Opened ICUs of a University-Affiliated Hospital of South Korea.

Authors:  Bo Min Kim; Eun Ju Jeon; Ju Young Jang; Jin-Won Chung; Jihoon Park; Jae Chol Choi; Jong Wook Shin; In Won Park; Byoung Whui Choi; Jae Yeol Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-04-30

Review 2.  Acinetobacter infections: a growing threat for critically ill patients.

Authors:  M E Falagas; E A Karveli; I I Siempos; K Z Vardakas
Journal:  Epidemiol Infect       Date:  2007-09-25       Impact factor: 2.451

3.  Comparison of risk factors for recovery of Acinetobacter baumannii during outbreaks at two Kentucky hospitals, 2006.

Authors:  Suzanne F Beavers; David B Blossom; Timothy L Wiemken; Kelly Y Kawaoka; Andrew Wong; Linda Goss; Malkanthie I McCormick; Douglas Thoroughman; Arjun Srinivasan
Journal:  Public Health Rep       Date:  2009 Nov-Dec       Impact factor: 2.792

4.  Antibacterial susceptibility patterns and cross-resistance of acinetobacter, isolated from hospitalized patients, southern iran.

Authors:  S Japoni; S Farshad; A Abdi Ali; A Japoni
Journal:  Iran Red Crescent Med J       Date:  2011-11-01       Impact factor: 0.611

5.  Clinical and antimicrobial profile of Acinetobacter spp.: An emerging nosocomial superbug.

Authors:  Purti C Tripathi; Sunita R Gajbhiye; Gopal Nandlal Agrawal
Journal:  Adv Biomed Res       Date:  2014-01-09

6.  Acinetobacter baumannii in intensive care unit: a novel system to study clonal relationship among the isolates.

Authors:  Carla Fontana; Marco Favaro; Silvia Minelli; Maria Cristina Bossa; Gian Piero Testore; Francesca Leonardis; Silvia Natoli; Cartesio Favalli
Journal:  BMC Infect Dis       Date:  2008-06-08       Impact factor: 3.090

7.  Frequency, risk factors, and antibiogram of Acinetobacter species isolated from various clinical samples in a tertiary care hospital in Odisha, India.

Authors:  Muktikesh Dash; Sanghamitra Padhi; Swetlana Pattnaik; Indrani Mohanty; Pooja Misra
Journal:  Avicenna J Med       Date:  2013-10

8.  Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008-2013.

Authors:  Antonella Agodi; Martina Barchitta; Annalisa Quattrocchi; Andrea Maugeri; Eugenia Aldisio; Anna Elisa Marchese; Anna Rita Mattaliano; Athanassios Tsakris
Journal:  Antimicrob Resist Infect Control       Date:  2015-11-03       Impact factor: 4.887

9.  Analysis of Acinetobacter baumannii hospital infections in patients treated at the intensive care unit of the University Hospital, Wroclaw, Poland: a 6-year, single-center, retrospective study.

Authors:  Wieslawa Duszynska; Agnieszka Litwin; Stanislaw Rojek; Aleksander Szczesny; Alfonso Ciasullo; Waldemar Gozdzik
Journal:  Infect Drug Resist       Date:  2018-05-01       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.